Fei Song

3.1k total citations
54 papers, 2.2k citations indexed

About

Fei Song is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Fei Song has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Fei Song's work include Signaling Pathways in Disease (9 papers), Galectins and Cancer Biology (7 papers) and MicroRNA in disease regulation (4 papers). Fei Song is often cited by papers focused on Signaling Pathways in Disease (9 papers), Galectins and Cancer Biology (7 papers) and MicroRNA in disease regulation (4 papers). Fei Song collaborates with scholars based in China, United States and Germany. Fei Song's co-authors include Yuan Gao, Knut Stieger, Zhi‐Nan Chen, Jian‐Li Jiang, Xiang-Min Yang, Li Wang, Jin Young Shin, Di Wang, Tianyi Yu and Peilang Yang and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Hepatology.

In The Last Decade

Fei Song

54 papers receiving 2.1k citations

Peers

Fei Song
Han Chen China
Junlin Li China
Jordy Saravia United States
Hong Chen China
Yu Hu China
Zhao Yang China
Rui Wei China
Zhenguo Liu China
Linfu Zhou China
Han Chen China
Fei Song
Citations per year, relative to Fei Song Fei Song (= 1×) peers Han Chen

Countries citing papers authored by Fei Song

Since Specialization
Citations

This map shows the geographic impact of Fei Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Song more than expected).

Fields of papers citing papers by Fei Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Song. The network helps show where Fei Song may publish in the future.

Co-authorship network of co-authors of Fei Song

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Song. A scholar is included among the top collaborators of Fei Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Song. Fei Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Song, Fei, et al.. (2022). Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines. International Journal of Molecular Sciences. 23(21). 13508–13508. 7 indexed citations
3.
Mao, Liang, Yun‐Da Li, Gang� Li, et al.. (2022). Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy. Journal of Nanobiotechnology. 20(1). 435–435. 26 indexed citations
4.
Dai, Qingqing, et al.. (2022). Recent Advances in Liver Engineering With Decellularized Scaffold. Frontiers in Bioengineering and Biotechnology. 10. 831477–831477. 34 indexed citations
5.
6.
Song, Fei, Chuan Liu, Junyong Zhang, & Zili Hu. (2020). Renal cell carcinoma with nephrotic syndrome: a case report and literature review. Translational Andrology and Urology. 9(3). 1459–1465. 10 indexed citations
7.
Song, Fei, et al.. (2019). Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones. International Urology and Nephrology. 52(4). 645–654. 7 indexed citations
8.
Song, Fei, Gaohua Liu, G.V.T. Swapna, et al.. (2018). Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2. Biochemistry. 57(47). 6581–6591. 16 indexed citations
9.
Lin, Jing, Fei Song, Zhenyu Liu, et al.. (2017). MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Letters. 414. 136–146. 45 indexed citations
10.
Song, Fei & Knut Stieger. (2017). Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks. Molecular Therapy — Nucleic Acids. 7. 53–60. 108 indexed citations
11.
Wu, Bo, Jian Cui, Xiang-Min Yang, et al.. (2017). Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy. Cell Death and Disease. 8(7). e2925–e2925. 34 indexed citations
12.
Li, Xiao, Xia Lv, Liang Xu, et al.. (2017). Exo70 is an independent prognostic factor in colon cancer. Scientific Reports. 7(1). 5039–5039. 10 indexed citations
13.
Song, Fei, Yuxiang Ma, Xueyuan Bai, & Xiangmei Chen. (2015). The Expression Changes of Inflammasomes in the Aging Rat Kidneys. The Journals of Gerontology Series A. 71(6). 747–756. 26 indexed citations
14.
Liu, Huijuan, Chengyu Zhang, Fei Song, et al.. (2015). A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes. Journal of Pharmacology and Experimental Therapeutics. 353(3). 573–581. 12 indexed citations
15.
Li, Zhen, Ke Jiang, Xiaofang Zhu, et al.. (2015). Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells. Cancer Letters. 370(2). 332–344. 86 indexed citations
16.
Wu, Jiao, Xiang-Min Yang, Hao Tang, et al.. (2014). Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma. Journal of Translational Medicine. 12(1). 190–190. 37 indexed citations
17.
Prorok-Hamon, Maëlle, Melissa K. Friswell, Carol L. Roberts, et al.. (2013). Colonic mucosa-associated diffusely adherentafaC+ Escherichia coliexpressinglpfAandpksare increased in inflammatory bowel disease and colon cancer. Gut. 63(5). 761–770. 185 indexed citations
18.
Song, Fei, Xin Zhang, Yifei Li, et al.. (2011). An efficient method for refolding the extracellular portion of CD147 from the total bacterial lysate. Acta Biochimica et Biophysica Sinica. 43(11). 900–908. 1 indexed citations
19.
Li, Yong, Jiao Wu, Fei Song, et al.. (2011). Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin β1 to Modulate Malignant Properties of Hepatoma Cells. Journal of Biological Chemistry. 287(7). 4759–4772. 61 indexed citations
20.
Song, Fei, et al.. (2004). The short term effect of pressure therapy and silicone gel on controlling the hypertrophic scar. PolyU Institutional Research Archive (Hong Kong Polytechnic University). 26(8). 462–465. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Chen Breakdown of academic impact, for papers by Junlin Li Breakdown of academic impact, for papers by Jordy Saravia Breakdown of academic impact, for papers by Hong Chen Breakdown of academic impact, for papers by Yu Hu Breakdown of academic impact, for papers by Zhao Yang Breakdown of academic impact, for papers by Rui Wei Breakdown of academic impact, for papers by Zhenguo Liu Breakdown of academic impact, for papers by Linfu Zhou
Rankless by CCL
2026